BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang R, He YT, Liu YS, Li H, Zhao F. Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4th-line therapy with anlotinib: A case report. World J Clin Cases 2024; 12(23): 5410-5415 [PMID: 39156099 DOI: 10.12998/wjcc.v12.i23.5410]
URL: https://www.wjgnet.com/2307-8960/full/v12/i23/5410.htm
Number Citing Articles
1
Cisplatin/etoposide/paclitaxelReactions Weekly 2024; 2020(1): 146 doi: 10.1007/s40278-024-64511-z